Overview
Tolerability of Grazax in Patients With Hayfever in Real Life Settings
Status:
Completed
Completed
Trial end date:
2010-12-01
2010-12-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to assess the safety profile of specific immunotherapy with Grazax for three consecutive grass pollen seasons.Phase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
ALK-Abelló A/S
Criteria
Inclusion Criteria:- History of grass pollen allergy
- Positive skin prick-test and/or positive specific IgE to grass
Exclusion Criteria:
- Severe, unstable or uncontrolled asthma (FEV1<70% of predicted value)